People who are dyslexic, dyspraxic, autistic or who have ADHD (specific learning disabilities [spLD]) are sometimes referred to as being neurodiverse or neurodivergent.
Sara Rankin is a Professor of Leukocyte and Stem Cell Biology in the Faculty of Medicine at Imperial College London in the UK. She is a world leader in the field of Regenerative Pharmacology, inventing drugs to help the body repair itself after injury. Prof Rankin is neurodiverse and in recent years has worked on educational and outreach projects to improve work environments and support neurodiverse staff, such that they can work to their full potential.
Prof Rankin’s seminar will explain the strengths and weaknesses associated with being neurodiverse and how this affects student learning and staff in the workplace in the academic context. She will describe why she thinks being dyslexic herself makes her an excellent scientist and how businesses are now recognising the value of neurodiversity in the workplace.
A link to connect to the seminar will be sent in advance of the date to the email address provided upon registration in the link below:
https://survey.ki.se/Survey/26886 (please register by the 3rd of October)